Skip to main content
. 2022 Feb 2;30:100842. doi: 10.1016/j.ymgmr.2022.100842

Table 3.

Comparison of acute manifestations among Groups A (median 36 years, range 15–49 years) and B (median 64 years, range 50–85 years).


AIP
VP
HCP
TOTAL
A B A B A B A B
No. of patients 32 33 11 29 1 1 44 63
Follow up fertile years 631 1221 269 1073 25 37 925 2331
Asymptomatic (%) 14 (44) 7 (21) 3 (27) 13 (45) 0 0 17 (39) 20 (32)
p 0.066 0.473 0.537
Symptomatic (%) 18 (56) 26 (79) 8 (73) 16 (55) 1 1 27 (61) 43 (68)
p 0.052 0.312 0.461
Acute symptoms solely (%)
(no hospitalization)
14 (44) 4 (12) 5 (45) 4 (14) 0 0 19 (43) 8 (13)
p 0.004* 0.032* 0.0004*
No. of patients with hospitalization (%) 4 (13) 22 (67) 3 (27) 12 (41) 1 1 8 (18) 35 (56)
p <0.001* 0.486 <0.001*
No. of patients with recurrent attacks 3 0 0 0 0 0 3 0
Mean of acute attacks per hospitalized patient 1 2.45 ± 1.74 1.33 ± 0.58 2.42 ± 1.31 1/1 1/1 1.2 ± 0.45 2.4 ± 1.58
p 0.422 0.064 0.002*
Ratio of acute attacks per patient during fertile years1 0.0013±
0.0071
0.0442±
0.0496
0.0112±
0.0202
0.0270±
0.0396
0.0049±
0.0137
0.0360±
0.0453
p <0.001* 0.106 <0.001*
No. of patients treated with hematin 3 2 2 7 1 0 62 93

1Follow up fertile years, 12–49 years of age; 2Hematin treatment during >100 attacks (1994 – 2015); 3Hematin treatment during 21 attacks (1980 – 2013).